Practice Management News

According to a recent study, more than half of the United States population eligible for semaglutide could lose at least 15% of their body weight after treatment with the medication.

As the pediatric mental health emergency continues, its effects on children continues to be a focus of research.

In this episode, host Shikha Jain, MD, speaks with St. Jude’s Steven Gottschalk, MD, and Paulina Velasquez, MD, about the evolution of bone marrow transplant and cell therapy, increasing accessibility to CAR T-cell therapy and more.

Women who quit smoking and were treated with the GLP-1 receptor agonist dulaglutide were less likely to experience substantial weight gain compared with those who received placebo, according to researchers.

SARS-CoV-2 rebound risk is more likely related to the individual person, rather than reinfection or resistance to treatment such as Paxlovid, according to two studies.

Efforts to raise flagging childhood vaccination rates increased in 2023 as new shots hit the market.

Earlier this year, a national report card noted the primary care field is headed for a crisis due to underinvestment, poor accessibility and other factors.

Hispanic, Black and Asian children have unmet mental health treatment needs compared with their white peers, according to a study in Pediatrics.

Below is a list of stories involving substance use and children that were published by Healio in 2023.

The FDA in 2023 approved treatments for several hospital-associated infections and fully approved a long-used COVID-19 medication, among other non-vaccine-related regulatory decisions.